Celularity Inc. Inventory
Celularity Inc. (CELU) had Inventory of $571.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-04-30
- 2025-12-31: Inventory, Net $571.00K.
- 2025-09-30: Inventory, Net $2.56M.
- 2025-06-30: Inventory, Net $4.41M.
- 2025-03-31: Inventory, Net $6.20M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2025-12-31 | $571.00K 10-K · filed 2026-04-30 | |
| 2025-09-30 | $2.56M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $4.41M 10-Q · filed 2025-08-29 | |
| 2025-03-31 | $6.20M 10-Q · filed 2025-08-29 | |
| 2024-12-31 | $5.41M 10-K · filed 2026-04-30 | |
| 2024-09-30 | $3.96M 10-Q · filed 2024-12-06 | |
| 2024-06-30 | $2.92M 10-Q · filed 2024-11-07 | |
| 2024-03-31 | $3.70M 10-Q · filed 2024-10-16 | |
| 2023-12-31 | $5.75M 10-K · filed 2025-05-08 | |
| 2023-09-30 | $4.93M 10-Q · filed 2024-01-03 | |
| 2023-06-30 | $5.74M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $5.48M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $5.31M 10-K · filed 2024-07-30 | |
| 2022-09-30 | $5.24M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $24.66M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $14.71M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $9.55M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $5.75M 10-Q · filed 2021-11-12 | |
| 2020-12-31 | $9.55M 10-Q · filed 2022-05-16 | $3.85M 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |